Wird geladen...

Advances in PSMA theranostics

The validation of prostate specific membrane antigen (PSMA) as a molecular target in metastatic castration-resistant prostate cancer has stimulated the development of multiple classes of theranostic ligands that specifically target PSMA. Theranostic ligands are used to image disease or selectively d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Thomas M. Jeitner, John W. Babich, James M. Kelly
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2022-08-01
Schriftenreihe:Translational Oncology
Schlagworte:
Online Zugang:http://www.sciencedirect.com/science/article/pii/S1936523322001097
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!